SOPHiA GENETICS (SOPH) Equity Average (2020 - 2025)

SOPHiA GENETICS has disclosed Equity Average across 6 years of filings, most recently posting -$69.4 million for Q4 2025.

• Equity Average for Q4 2025 came in at -$69.4 million, down 26.4% year-over-year; the trailing twelve-month figure through Dec 2025 was -$69.4 million (down 26.4% YoY), and the FY2025 annual result was -$70.7 million, changed 0.01% from the prior year.
• Equity Average came in at -$69.4 million for Q4 2025 at SOPHiA GENETICS, down from -$10.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $12.3 million in Q2 2022 to a low of -$80.5 million in Q4 2022.
• The 5-year median for Equity Average is -$33.0 million (2021), against an average of -$30.5 million.
• Peak annual rise in Equity Average reached 156.44% in 2022, while the deepest fall reached 90.67% in 2022.
• SOPHiA GENETICS's Equity Average stood at -$63.0 million in 2021, then slipped by 27.74% to -$80.5 million in 2022, then advanced by 16.79% to -$67.0 million in 2023, then rose by 17.98% to -$54.9 million in 2024, then fell by 26.4% to -$69.4 million in 2025.
• The last three Equity Average figures came in at -$69.4 million (Q4 2025), -$10.0 million (Q3 2025), and $11.2 million (Q2 2025), per Business Quant data.